Posts by Christopher Gallo
Petitioners challenging patents covering pharmaceuticals and biologics often use drug product labels as prior art in the Patent Trial and Appeal Board (PTAB). To effectively use a …
holds a PhD in Biochemistry and Molecular Genetics. His practice at Axinn is focused on patent litigation. Christopher's experience includes matters before federal district courts and the United States International Trade Commission in which he has been heavily involved in all aspects of litigation, from pre-filing investigation, through fact and expert-witness discovery, claim-construction, and trial. Christopher also has experience in patent reexaminations and in inter partes review proceedings before the Patent Trial and Appeal Board at the USPTO. Prior to joining the firm, Christopher worked as a postdoctoral fellow at the Johns Hopkins University School of Medicine.
For more information or to contact Christopher, please visit his Firm Profile Page.